Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of the Therapearl eye mask and Eyestil synfo eye drops constitutes a home-based therapeutic regimen used for the management of meibomian gland dysfunction (MGD) and evaporative dry eye disease. The Therapearl eye mask (Bausch & Lomb) is a medical device that utilizes heat therapy to soften and liquefy thickened meibum within the meibomian glands, facilitating its expression and improving the lipid layer of the tear film. Eyestil synfo (Sifi) is a hypotonic ophthalmic solution containing sodium hyaluronate and xanthan gum. It acts as a lubricant and mucomimetic to stabilize the tear film, reduce evaporation, and protect the ocular surface from hyperosmolarity-induced damage. This specific combination was evaluated by the University of Seville as a standard-of-care control and adjunctive therapy in clinical trials investigating advanced procedural interventions for dry eye.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Therapearl eye mask + Eyestil synfo.